the experience of single-agent daratumumab for r/r myeloma in india
Published 2 months ago • 59 plays • Length 0:54Download video MP4
Download video MP3
Similar videos
-
3:00
single-agent daratumumab activity in refractory multiple myeloma
-
2:09
the candor trial extended follow-up: daratumumab for r/r myeloma
-
2:04
a novel mechanism of action for daratumumab in myeloma
-
2:47
magnestismm-1: elranatamab alone or with immunomodulatory agents in r/r multiple myeloma
-
3:24
novel agents for the management of r/r myeloma
-
6:23
how long will i live with multiple myeloma and is there a cure?
-
5:59
what is hrmm (high-risk multiple myeloma)?
-
28:00
ucr ms symposium: evolutionary origin of stereodivergent glycoalkaloids (adam jozwiak)
-
5:07
daratumumab in the management of al amyloidosis
-
1:00
the recent fda approval of teclistamab for r/r multiple myeloma
-
0:52
the future of daratumumab in multiple myeloma
-
2:46
single use daratumumab for al amyloidosis
-
3:56
iv daratumumab in r/r myeloma: bodyweight analysis
-
0:59
defining the origins of multiple myeloma
-
1:09
the efficacy & role of iberdomide in r/r multiple myeloma
-
5:36
daratumumab shows remarkable benefit in relapsed or refractory multiple myeloma in the pollux trial
-
2:16
mechanism of action & use of daratumumab in multiple myeloma
-
1:06
daratumumab and carfilzomib for al amyloid neuropathy
-
2:29
phase i first-in-human study of alnuctamab in patients with r/r multiple myeloma
-
4:45
a first-in-human trial of linvoseltamab (regn5458) in r/r myeloma: updated phase i data
-
4:30
andromeda: daratumumab for al amyloidosis
-
2:09
dart4mm: daratumumab in myeloma patients with vgpr to first-line therapy